SCWorx Corp. (Nasdaq: WORX) announced today that it confirms previously disclosed plans to distribute COVID-19 Rapid Testing Units. Previously, the company announced receiving a committed purchase order from Rethink My Healthcare, a U.S.-based virtual healthcare network, for two million COVID-19 Rapid Testing Units, with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week.
Under the previously disclosed purchase order, SCWorx will supply Rethink My Healthcare with IgM/IgG Rapid Detection Kits. SCWorx continues to anticipate receiving the first 2 million rapid detection kits within approximately two weeks and looks forward to providing incremental updates as they become available.
Backup Power Is a Lifeline: What Healthcare Facility Managers Must Get Right
3 Pillars of Stronger Cybersecurity in Healthcare
Piedmont Fayette Hospital to Build New Patient Tower
Texas HHSC Announces Construction of New Lubbock Psychiatric Center
Armed Standoff at West Virginia Hospital Reminds of the Need for Safety Measures